Value of cross-sectional imaging in assessing active Crohn's disease before stoma reversal

Bastien Dirrenberger, Isabelle Clerc-Urmès, Adeline Germain, Laurent Bresler, Pablo Olivera, Laura Martelli, Silvio Danese, Cédric Baumann, Valérie Laurent, Laurent Peyrin-Biroulet

Research output: Contribution to journalArticle

Abstract

Background There are currently no guidelines on the need to assess disease activity before stoma reversal in Crohn's disease (CD). We sought to determine the value of cross-sectional imaging for detecting active CD before stoma reversal. Methods 38 CD patients underwent cross-sectional imaging before stoma reversal. CD activity was blindly evaluated by an independent radiologist. Postoperative outcomes were recorded. Results Before stoma reversal, cross-sectional imaging identified active CD in 20 of the 38 study participants (52.6%). In 9 out of 10 tested patients, radiologic and endoscopic assessments gave concordant findings with regard to CD recurrence before stoma reversal. Stoma reversal was delayed in half of the patients with active CD and in none of the patients without active CD. Before stoma reversal, tumor necrosis factor alpha antagonists or immunosuppressants were initiated in 45% of the patients with active CD and 5.6% of the patients without active CD. In the year following stoma reversal, the recurrence rate (in a radiologic assessment) was higher in patients with active CD than in patients without active CD (75.0% vs. 30.8%, respectively; p = 0.04). Conclusion Cross-sectional imaging revealed postoperative recurrence in about a quarter of patients before stoma reversal; this finding may influence the postoperative treatment strategy and outcomes.

Original languageEnglish
Pages (from-to)864-871
Number of pages8
JournalDigestive and Liver Disease
Volume49
Issue number8
DOIs
Publication statusPublished - Aug 1 2017

Fingerprint

Crohn Disease
Recurrence
Immunosuppressive Agents
Tumor Necrosis Factor-alpha
Guidelines

Keywords

  • Crohn's disease
  • Cross-sectional imaging
  • MRI
  • Postoperative recurrence
  • Temporary stoma

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Cite this

Dirrenberger, B., Clerc-Urmès, I., Germain, A., Bresler, L., Olivera, P., Martelli, L., ... Peyrin-Biroulet, L. (2017). Value of cross-sectional imaging in assessing active Crohn's disease before stoma reversal. Digestive and Liver Disease, 49(8), 864-871. https://doi.org/10.1016/j.dld.2017.03.028

Value of cross-sectional imaging in assessing active Crohn's disease before stoma reversal. / Dirrenberger, Bastien; Clerc-Urmès, Isabelle; Germain, Adeline; Bresler, Laurent; Olivera, Pablo; Martelli, Laura; Danese, Silvio; Baumann, Cédric; Laurent, Valérie; Peyrin-Biroulet, Laurent.

In: Digestive and Liver Disease, Vol. 49, No. 8, 01.08.2017, p. 864-871.

Research output: Contribution to journalArticle

Dirrenberger, B, Clerc-Urmès, I, Germain, A, Bresler, L, Olivera, P, Martelli, L, Danese, S, Baumann, C, Laurent, V & Peyrin-Biroulet, L 2017, 'Value of cross-sectional imaging in assessing active Crohn's disease before stoma reversal', Digestive and Liver Disease, vol. 49, no. 8, pp. 864-871. https://doi.org/10.1016/j.dld.2017.03.028
Dirrenberger B, Clerc-Urmès I, Germain A, Bresler L, Olivera P, Martelli L et al. Value of cross-sectional imaging in assessing active Crohn's disease before stoma reversal. Digestive and Liver Disease. 2017 Aug 1;49(8):864-871. https://doi.org/10.1016/j.dld.2017.03.028
Dirrenberger, Bastien ; Clerc-Urmès, Isabelle ; Germain, Adeline ; Bresler, Laurent ; Olivera, Pablo ; Martelli, Laura ; Danese, Silvio ; Baumann, Cédric ; Laurent, Valérie ; Peyrin-Biroulet, Laurent. / Value of cross-sectional imaging in assessing active Crohn's disease before stoma reversal. In: Digestive and Liver Disease. 2017 ; Vol. 49, No. 8. pp. 864-871.
@article{529be73c2b3542ad9f922cea40142a01,
title = "Value of cross-sectional imaging in assessing active Crohn's disease before stoma reversal",
abstract = "Background There are currently no guidelines on the need to assess disease activity before stoma reversal in Crohn's disease (CD). We sought to determine the value of cross-sectional imaging for detecting active CD before stoma reversal. Methods 38 CD patients underwent cross-sectional imaging before stoma reversal. CD activity was blindly evaluated by an independent radiologist. Postoperative outcomes were recorded. Results Before stoma reversal, cross-sectional imaging identified active CD in 20 of the 38 study participants (52.6{\%}). In 9 out of 10 tested patients, radiologic and endoscopic assessments gave concordant findings with regard to CD recurrence before stoma reversal. Stoma reversal was delayed in half of the patients with active CD and in none of the patients without active CD. Before stoma reversal, tumor necrosis factor alpha antagonists or immunosuppressants were initiated in 45{\%} of the patients with active CD and 5.6{\%} of the patients without active CD. In the year following stoma reversal, the recurrence rate (in a radiologic assessment) was higher in patients with active CD than in patients without active CD (75.0{\%} vs. 30.8{\%}, respectively; p = 0.04). Conclusion Cross-sectional imaging revealed postoperative recurrence in about a quarter of patients before stoma reversal; this finding may influence the postoperative treatment strategy and outcomes.",
keywords = "Crohn's disease, Cross-sectional imaging, MRI, Postoperative recurrence, Temporary stoma",
author = "Bastien Dirrenberger and Isabelle Clerc-Urm{\`e}s and Adeline Germain and Laurent Bresler and Pablo Olivera and Laura Martelli and Silvio Danese and C{\'e}dric Baumann and Val{\'e}rie Laurent and Laurent Peyrin-Biroulet",
year = "2017",
month = "8",
day = "1",
doi = "10.1016/j.dld.2017.03.028",
language = "English",
volume = "49",
pages = "864--871",
journal = "Digestive and Liver Disease",
issn = "1590-8658",
publisher = "Elsevier B.V.",
number = "8",

}

TY - JOUR

T1 - Value of cross-sectional imaging in assessing active Crohn's disease before stoma reversal

AU - Dirrenberger, Bastien

AU - Clerc-Urmès, Isabelle

AU - Germain, Adeline

AU - Bresler, Laurent

AU - Olivera, Pablo

AU - Martelli, Laura

AU - Danese, Silvio

AU - Baumann, Cédric

AU - Laurent, Valérie

AU - Peyrin-Biroulet, Laurent

PY - 2017/8/1

Y1 - 2017/8/1

N2 - Background There are currently no guidelines on the need to assess disease activity before stoma reversal in Crohn's disease (CD). We sought to determine the value of cross-sectional imaging for detecting active CD before stoma reversal. Methods 38 CD patients underwent cross-sectional imaging before stoma reversal. CD activity was blindly evaluated by an independent radiologist. Postoperative outcomes were recorded. Results Before stoma reversal, cross-sectional imaging identified active CD in 20 of the 38 study participants (52.6%). In 9 out of 10 tested patients, radiologic and endoscopic assessments gave concordant findings with regard to CD recurrence before stoma reversal. Stoma reversal was delayed in half of the patients with active CD and in none of the patients without active CD. Before stoma reversal, tumor necrosis factor alpha antagonists or immunosuppressants were initiated in 45% of the patients with active CD and 5.6% of the patients without active CD. In the year following stoma reversal, the recurrence rate (in a radiologic assessment) was higher in patients with active CD than in patients without active CD (75.0% vs. 30.8%, respectively; p = 0.04). Conclusion Cross-sectional imaging revealed postoperative recurrence in about a quarter of patients before stoma reversal; this finding may influence the postoperative treatment strategy and outcomes.

AB - Background There are currently no guidelines on the need to assess disease activity before stoma reversal in Crohn's disease (CD). We sought to determine the value of cross-sectional imaging for detecting active CD before stoma reversal. Methods 38 CD patients underwent cross-sectional imaging before stoma reversal. CD activity was blindly evaluated by an independent radiologist. Postoperative outcomes were recorded. Results Before stoma reversal, cross-sectional imaging identified active CD in 20 of the 38 study participants (52.6%). In 9 out of 10 tested patients, radiologic and endoscopic assessments gave concordant findings with regard to CD recurrence before stoma reversal. Stoma reversal was delayed in half of the patients with active CD and in none of the patients without active CD. Before stoma reversal, tumor necrosis factor alpha antagonists or immunosuppressants were initiated in 45% of the patients with active CD and 5.6% of the patients without active CD. In the year following stoma reversal, the recurrence rate (in a radiologic assessment) was higher in patients with active CD than in patients without active CD (75.0% vs. 30.8%, respectively; p = 0.04). Conclusion Cross-sectional imaging revealed postoperative recurrence in about a quarter of patients before stoma reversal; this finding may influence the postoperative treatment strategy and outcomes.

KW - Crohn's disease

KW - Cross-sectional imaging

KW - MRI

KW - Postoperative recurrence

KW - Temporary stoma

UR - http://www.scopus.com/inward/record.url?scp=85018663623&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018663623&partnerID=8YFLogxK

U2 - 10.1016/j.dld.2017.03.028

DO - 10.1016/j.dld.2017.03.028

M3 - Article

VL - 49

SP - 864

EP - 871

JO - Digestive and Liver Disease

JF - Digestive and Liver Disease

SN - 1590-8658

IS - 8

ER -